Morgan Stanley Elanco Animal Health Inc Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Morgan Stanley holds 9,972,113 shares of ELAN stock, worth $216 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,972,113
Previous 4,694,468
112.42%
Holding current value
$216 Million
Previous $49.3 Million
188.9%
% of portfolio
0.01%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding ELAN
# of Institutions
425Shares Held
484MCall Options Held
868KPut Options Held
1.42M-
Dodge & Cox San Francisco, CA82.9MShares$1.79 Billion0.71% of portfolio
-
Primecap Management CO Pasadena, CA51.8MShares$1.12 Billion0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA47.8MShares$1.03 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$504 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX22.7MShares$492 Million0.08% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $10.3B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...